Ardent Health (ARDT) UBS Global Healthcare Conference summary

Operational performance and IMPACT

• IMPACT is a multi-year program; at least $70M in contribution savings expected this year, with $20M–$25M carrying into 2027 if no further initiatives are added.

• Q3 earnings highlighted a 4% improvement in salaries, wages and benefits; management described the work as durable and sustainable.

• Margin expansion remains a multi-year priority, with at least three more years of IMPACT work; the previously discussed mid-teens EBITDA margin ambition predates BBB and Medicaid supplemental cuts.

• CORE opened in mid-October, consolidating patient placement and transfer centers from 30 to 13 to three to one; expected benefits include lower staffing costs, productivity gains and quality assurance.

• Professional-fee growth moderated from 13% YoY in Q1 to 7.5% in Q3; high-single-digit growth expected in Q4, with 2027 expected to improve on 2026 but remain above inflation.

Demand and service lines

• Surgical demand has been weaker than expected, while demand at the top of the funnel remains strong; management cited high-single-digit urgent-care demand and provider growth in the single digits plus.

• Q3 adjusted admissions rose 2.9%, while inpatient admissions were flat; management is focused on converting referrals into specialty visits and completed surgeries.

• Commercial and exchange volumes faced pressure from higher deductibles; 12% of the exchange book shifted from Silver to Bronze, and management cited potential deferred-care demand.

• Capacity IQ has been optimizing service mix, including lower-margin procedures; 2027 is expected to focus more on growth and smart additions than optimization.

• Organic service-line decisions will be tailored to local markets; management cited opportunities across maternal and baby care.

Pricing and payer contracting

• Revenue per adjusted admission was up 0.7% in Q3; full-year pricing was expected to rise just under 1%, affected by lower acuity, weaker surgical flow and payer mix.

• 85% of 2027 and 75% of 2028 payer contracts were completed; 2027 is a lighter commercial renewal year.

• Four key negotiations in 2026 delivered rate increases above plan and historical levels, with multi-year terms; the increases support more competitive market rates.

• A finalized outpatient Medicare payment change could provide up to $10M of bottom-line benefit next year, subject to the policy remaining in place.